Position
Co-Chief Executive Officer
Company
Apimeds Pharmaceuticals US
MatawanBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Sungjoon Chae became Co-Chief Executive Officer of Apimeds Pharmaceuticals US on October 1, 2026, per the SEC Form 3 filed November 5, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
Quick answer
Apimeds Pharmaceuticals US Names Sungjoon Chae Co-Chief Executive Officer (November 6, 2026). Apimeds Pharmaceuticals US is based in Matawan, New Jersey, United States.
- Who is the new Co-Chief Executive Officer at Apimeds Pharmaceuticals US?
- Apimeds Pharmaceuticals US named Sungjoon Chae Co-Chief Executive Officer, announced November 6, 2026.
- What did Apimeds Pharmaceuticals US announce on November 6, 2026?
- Sungjoon Chae became Co-Chief Executive Officer of Apimeds Pharmaceuticals US on October 1, 2026, per the SEC Form 3 filed November 5, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
- What does Apimeds Pharmaceuticals US do?
- Apimeds is a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered honeybee venom-based toxin.
- Where is Apimeds Pharmaceuticals US based?
- Apimeds Pharmaceuticals US is based in Matawan, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- Candel Therapeutics (November 6, 2026), Pfizer (November 5, 2026), Alnylam Pharmaceuticals (November 5, 2026) and Tempest Therapeutics (November 4, 2026) also announced leadership changes within 45 days of Apimeds Pharmaceuticals US.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Candel Therapeutics names Maria Ostrovsky General Counsel (November 6, 2026)
- Pfizer Appoints Cecile Guegan as CFO and Omnicom Health Names Tom Schwenger as CEO (November 5, 2026)
- Alnylam Pharmaceuticals Announces Departure of Executive Vice President (November 5, 2026)
- Tempest Therapeutics names Stephanie Horn-Warnock CFO, Treasurer, & Corp Sec. (November 4, 2026)
- GemVax & KAEL Appoints Lee Jae-hong as Chief Medical Officer (November 4, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
Who to call at Apimeds Pharmaceuticals US, and when
A new leader at Apimeds Pharmaceuticals US brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Apimeds Pharmaceuticals US raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Apimeds Pharmaceuticals US, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Apimeds Pharmaceuticals US. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Apimeds Pharmaceuticals US changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Apimeds Pharmaceuticals US changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.